A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer diseaseStephen Salloway, Anton P. Porsteinsson, C H van Dyck et al.|Neurology|2011Cited by 255
Can we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's diseaseMaría C. Carrillo, Reisa A. Sperling, H. Robert Brashear et al.|Alzheimer s & Dementia|2013Cited by 122